|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/66 | |
| A61K 31/325 | |||
| A61K 31/165 | |||
| A61K 47/10 | |||
| A61K 9/00 |
| (11) | Number of the document | 1773353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05773490.7 |
| Date of filing the European patent application | 2005-07-15 | |
| (97) | Date of publication of the European application | 2007-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-02-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/025224 |
| Date | 2005-07-15 |
| (87) | Number | WO 2006/010152 |
| Date | 2006-01-26 |
| (30) | Number | Date | Country code |
| 589075 P | 2004-07-19 | US |
| (72) |
BELL, Staneley, C., US
WONG, Albert, US
MANIAR, Manoj, US
|
| (73) |
Onconova Therapeutics, Inc.,
375 Pheasant Run, Newtown, PA 18940,
US
|
| (54) | FORMULATIONS FOR PARENTERAL ADMINISTRATION OF (E)-2,6-DIALKOXYSTRYRYL 4-SUBSTITUTED BENZYLSULFONES |
| FORMULATIONS FOR PARENTERAL ADMINISTRATION OF (E)-2,6-DIALKOXYSTRYRYL 4-SUBSTITUTED BENZYLSULFONES |